| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |